SCHEMBL8549571

SCHEMBL8549571

CCCCOc1ccc2[nH]cc(CC#N)c2c1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 10/20 0.37
CSNK2A1 P68400 3/20 0.37
HTR1A P08908 9/20 0.37
HTR1D P28221 8/20 0.37
MAPT P10636 2/20 0.36
MAPK1 P28482 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
HTR2A P28223 1/20 0.36
CYP2C19 P33261 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GLA P06280 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8544872 0.94 CSNK2A1 (0.38) HTR1BCSNK2A1HTR1AHTR1DMAPT
SCHEMBL8548477 0.83 HTR1A (0.42) CSNK2A1HTR1AHTR2A
SCHEMBL8549767 0.81 HTR2A (0.44) HTR1BHTR1AHTR1DMAPTMAPK1
SCHEMBL8545440 0.79 HTR1A (0.55) HTR1BHTR1AHTR1DCYP1A2CYP2D6
SCHEMBL8549558 0.79 HTR2A (0.45) CSNK2A1HTR1DMAPTMAPK1KDM4E
SCHEMBL8869470 0.76 CSNK2A1 (0.38) CSNK2A1MAPTTDP1CYP1A2CYP3A4
SCHEMBL8549160 0.74 HTR2A (0.45) HTR1BCSNK2A1HTR1AHTR1DMAPT
SCHEMBL8543442 0.74 HTR1A (0.54) HTR1BCSNK2A1HTR1AHTR1DMAPT
Hexane SCHEMBL27942675 0.74 GPR84 (0.56) CSNK2A1HTR1AHTR2APDE4D
SCHEMBL8543561 0.73 HTR2A (0.46) HTR1BHTR1AHTR1DTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593513-B1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1998-10-28 EP disclosed
US-5571833-A TREATMENT OF MIGRAINE, PORTAL HYPERTENSION SMITHKLINE BEECHAM PLC (GB) 1996-11-05 US disclosed
EP-0593513-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1994-04-27 EP disclosed
WO-1993000333-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-01-07 WO disclosed